Bactericidal Effects: Microbial Nanoparticles as Next-Generation Antimicrobials

Kodaparthi, Ashwitha; Hameeda, Bee; Bastipati, Suresh Babu; Golla, Shaine

doi:10.1007/978-981-99-2808-8_12

Cited by 1 publication

(1 citation statement)

References 81 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Besides all the properties of silver ions, also in the form of Ag 0 nanoparticles, silver shows tremendous potential as an antibacterial agent [8][9][10][11], currently used in numerous consumer and medical products [12][13][14]. However, silver nanoparticles (AgNPs) have several drawbacks that must be studied [15].…”

Section: Introductionmentioning

confidence: 99%

Microalga Broths Synthesize Antibacterial and Non-Cytotoxic Silver Nanoparticles Showing Synergy with Antibiotics and Bacterial ROS Induction and Can Be Reused for Successive AgNP Batches

Pernas-Pleite,

Conejo-Martínez,

Fernández Freire

et al. 2023

IJMS

View full text Add to dashboard Cite

The era of increasing bacterial antibiotic resistance requires new approaches to fight infections. With this purpose, silver-based nanomaterials are a reality in some fields and promise new developments. We report the green synthesis of silver nanoparticles (AgNPs) using culture broths from a microalga. Broths from two media, with different compositions and pHs and sampled at two growth phases, produced eight AgNP types. Nanoparticles harvested after several synthesis periods showed differences in antibacterial activity and stability. Moreover, an evaluation of the broths for several consecutive syntheses did not find relevant kinetics or activity differences until the third round. Physicochemical characteristics of the AgNPs (core and hydrodynamic sizes, Z-potential, crystallinity, and corona composition) were determined, observing differences depending on the broths used. AgNPs showed good antibacterial activity at concentrations producing no or low cytotoxicity on cultured eukaryotic cells. All the AgNPs had high levels of synergy against Escherichia coli and Staphylococcus aureus with the classic antibiotics streptomycin and kanamycin, but with ampicillin only against S. aureus and tetracycline against E. coli. Differences in the synergy levels were also dependent on the types of AgNPs. We also found that, for some AgNPs, the killing of bacteria started before the massive accumulation of ROS.

show abstract